Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma

clinical trial

Details

Instance of: clinical trial
Start time: December 2011
End time: December 2013
Country: Australia, Hungary, India, Romania, Ukraine, United States
Main subject: sarcoma
clinical trial phase: phase II clinical trial
maximum age: 80
minimum age: 15
number of participants: 105
research intervention: doxorubicin, Caelyx
research site: Stanford University, Royal Hobart Hospital, Christian Medical College Vellore, University of Iowa Health Care, University of Western Australia
study type: interventional study
title: A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma

Nothing in the MetaHistoryBook collection references this item yet.